[go: up one dir, main page]

PA8650501A1 - Sintesis asimetrica de derivados de dihidrobenzofurano - Google Patents

Sintesis asimetrica de derivados de dihidrobenzofurano

Info

Publication number
PA8650501A1
PA8650501A1 PA20058650501A PA8650501A PA8650501A1 PA 8650501 A1 PA8650501 A1 PA 8650501A1 PA 20058650501 A PA20058650501 A PA 20058650501A PA 8650501 A PA8650501 A PA 8650501A PA 8650501 A1 PA8650501 A1 PA 8650501A1
Authority
PA
Panama
Prior art keywords
asymmetric synthesis
dihydrobenzofuran derivatives
derivatives
dihydrobenzofuran
asymmetric
Prior art date
Application number
PA20058650501A
Other languages
English (en)
Inventor
Gary Paul Stack
Dahui Zhou
Alexander V Gontcharov
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of PA8650501A1 publication Critical patent/PA8650501A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Furan Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

ESTA INVENCION SE REFIERE A UN PROCESO PARA LA PREPARACION DE DERIVADOS DE BENZOFURANO. EN ALGUNOS ASPECTOS, ESTOS COMPUESTOS DE LA FORMULA I: EN DONDE CADA R1, R3 Y R4 ES COMO SE DEFINE AQUI.
PA20058650501A 2004-10-21 2005-10-21 Sintesis asimetrica de derivados de dihidrobenzofurano PA8650501A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62102304P 2004-10-21 2004-10-21

Publications (1)

Publication Number Publication Date
PA8650501A1 true PA8650501A1 (es) 2006-07-03

Family

ID=35965910

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20058650501A PA8650501A1 (es) 2004-10-21 2005-10-21 Sintesis asimetrica de derivados de dihidrobenzofurano

Country Status (14)

Country Link
US (1) US20060089405A1 (es)
EP (1) EP1802598A2 (es)
JP (1) JP2008517929A (es)
CN (1) CN101107238A (es)
AR (1) AR053980A1 (es)
AU (1) AU2005299757A1 (es)
BR (1) BRPI0516236A (es)
CA (1) CA2584775A1 (es)
GT (1) GT200500296A (es)
MX (1) MX2007004637A (es)
PA (1) PA8650501A1 (es)
PE (1) PE20061033A1 (es)
TW (1) TW200619215A (es)
WO (1) WO2006047288A2 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050261347A1 (en) * 2003-10-24 2005-11-24 Wyeth Dihydrobenzofuranyl alkanamine derivatives and methods for using same
US7435837B2 (en) 2003-10-24 2008-10-14 Wyeth Dihydrobenzofuranyl alkanamine derivatives and methods for using same
GT200500297A (es) * 2004-10-21 2006-10-27 Sintesis asimetrica de dehidrobenzofuranos sustituidos
CA2605580A1 (en) * 2005-04-22 2006-11-02 Wyeth Benzodioxane and benzodioxolane derivatives and uses thereof
BRPI0610785A2 (pt) * 2005-04-22 2016-09-13 Wyeth Corp polimorfo cristalino, processo para preparar o mesmo, forma cristalina, composição, e, métodos para tratar uma doença, distúrbios, e uma condição
TW200716595A (en) * 2005-04-22 2007-05-01 Wyeth Corp Chromane and chromene derivatives and uses thereof
AU2006239922A1 (en) * 2005-04-22 2006-11-02 Wyeth Benzofuranyl alkanamine derivatives and uses thereof as 5-HT2c agonists
AU2006239918A1 (en) * 2005-04-22 2006-11-02 Wyeth New therapeutic combianations for the treatment or prevention of depression
PE20070093A1 (es) * 2005-04-22 2007-02-07 Wyeth Corp Derivados dihidrobenzofuranos como moduladores del receptor 5-ht2c
AU2006239943A1 (en) * 2005-04-22 2006-11-02 Wyeth Treatment of pain
AU2006239910A1 (en) * 2005-04-22 2006-11-02 Wyeth Dihydrobenzofuran derivatives and uses thereof
GT200600164A (es) * 2005-04-22 2007-03-14 Derivados de dihidrobenzofuranos y usos de los mismos
JP2008538582A (ja) * 2005-04-22 2008-10-30 ワイス 精神病性障害の治療または予防のための新規の治療的組み合わせ
WO2006116169A2 (en) * 2005-04-24 2006-11-02 Wyeth Methods for modulating bladder function
TW200806287A (en) * 2006-03-24 2008-02-01 Wyeth Corp Methods for treating cognitive and other disorders
WO2012030953A1 (en) 2010-09-01 2012-03-08 Arena Pharmaceuticals, Inc. 5-ht2c receptor agonists in the treatment of disorders ameliorated by reduction of norepinephrine level
GB2486631A (en) * 2010-12-01 2012-06-27 Univ Sheffield Phenol/quinone boronic acids/esters and method of preparation thereof
WO2015066344A1 (en) 2013-11-01 2015-05-07 Arena Pharmaceuticals, Inc. 5-ht2c receptor agonists and compositions and methods of use
CN109776465B (zh) * 2019-03-22 2023-06-06 国网湖南省电力有限公司 一种具有c2季碳中心的苯并二氢呋喃衍生物的合成方法
CN110283150A (zh) * 2019-07-12 2019-09-27 南开大学 一类手性二氢苯并呋喃的不对称合成方法
EP3878447A1 (en) 2020-03-11 2021-09-15 InterAx Biotech AG Beta adrenergic receptor antagonists
CN114560754A (zh) * 2022-02-25 2022-05-31 滁州学院 一种烷基醇的制备方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100327264B1 (ko) * 1993-10-29 2002-07-02 요시히로 미와 인돌유도체,그의염및이를함유하는심질환치료제
EP0769496A4 (en) * 1994-07-07 2001-10-17 Asahi Chemical Ind 2,3-DIHYDROBENZOFURAN DERIVATIVES, METHOD FOR THE PRODUCTION AND USE THEREOF
JPH09227562A (ja) * 1996-02-23 1997-09-02 Kowa Co インドール誘導体の製造法
JP2000007671A (ja) * 1998-06-25 2000-01-11 Asahi Chem Ind Co Ltd ２，３−ジヒドロベンゾフラン誘導体
JP2000080091A (ja) * 1998-06-26 2000-03-21 Asahi Chem Ind Co Ltd ２，３―ジヒドロベンゾフラン誘導体の製造方法
MXPA04003086A (es) * 2001-10-05 2004-09-06 Wyeth Corp Proceso para sintesis estereoselectiva de 2-hidroximetil-cromanos.
US20050261347A1 (en) * 2003-10-24 2005-11-24 Wyeth Dihydrobenzofuranyl alkanamine derivatives and methods for using same
US7728155B2 (en) * 2003-10-24 2010-06-01 Wyeth Llc Dihydrobenzofuranyl alkanamines and methods for using same as cns agents
US7435837B2 (en) * 2003-10-24 2008-10-14 Wyeth Dihydrobenzofuranyl alkanamine derivatives and methods for using same
US7516224B2 (en) * 2004-10-21 2009-04-07 Cisco Technology, Inc. Pseudowire termination directly on a router
GT200500297A (es) * 2004-10-21 2006-10-27 Sintesis asimetrica de dehidrobenzofuranos sustituidos
GT200600164A (es) * 2005-04-22 2007-03-14 Derivados de dihidrobenzofuranos y usos de los mismos
AU2006239943A1 (en) * 2005-04-22 2006-11-02 Wyeth Treatment of pain
AU2006239910A1 (en) * 2005-04-22 2006-11-02 Wyeth Dihydrobenzofuran derivatives and uses thereof
TW200716595A (en) * 2005-04-22 2007-05-01 Wyeth Corp Chromane and chromene derivatives and uses thereof
CA2605580A1 (en) * 2005-04-22 2006-11-02 Wyeth Benzodioxane and benzodioxolane derivatives and uses thereof
PE20070093A1 (es) * 2005-04-22 2007-02-07 Wyeth Corp Derivados dihidrobenzofuranos como moduladores del receptor 5-ht2c
JP2008538766A (ja) * 2005-04-22 2008-11-06 ワイス 薬物乱用の処置
BRPI0610785A2 (pt) * 2005-04-22 2016-09-13 Wyeth Corp polimorfo cristalino, processo para preparar o mesmo, forma cristalina, composição, e, métodos para tratar uma doença, distúrbios, e uma condição
JP2008538582A (ja) * 2005-04-22 2008-10-30 ワイス 精神病性障害の治療または予防のための新規の治療的組み合わせ
AU2006239922A1 (en) * 2005-04-22 2006-11-02 Wyeth Benzofuranyl alkanamine derivatives and uses thereof as 5-HT2c agonists
AU2006239918A1 (en) * 2005-04-22 2006-11-02 Wyeth New therapeutic combianations for the treatment or prevention of depression
WO2006116169A2 (en) * 2005-04-24 2006-11-02 Wyeth Methods for modulating bladder function
US7593398B2 (en) * 2005-09-08 2009-09-22 Cisco Technology, Inc. Layer-two interworking applied to L2-L3 pseudowires

Also Published As

Publication number Publication date
AR053980A1 (es) 2007-05-30
PE20061033A1 (es) 2006-11-08
TW200619215A (en) 2006-06-16
BRPI0516236A (pt) 2008-08-26
AU2005299757A1 (en) 2006-05-04
GT200500296A (es) 2006-10-02
EP1802598A2 (en) 2007-07-04
JP2008517929A (ja) 2008-05-29
CA2584775A1 (en) 2006-05-04
CN101107238A (zh) 2008-01-16
WO2006047288A2 (en) 2006-05-04
WO2006047288A3 (en) 2007-03-15
MX2007004637A (es) 2007-06-08
US20060089405A1 (en) 2006-04-27

Similar Documents

Publication Publication Date Title
PA8650501A1 (es) Sintesis asimetrica de derivados de dihidrobenzofurano
CR11742A (es) Derivados de arilsulfonil pirazolin carboxamidina como antagonistas de 5-ht6
ECSP10010582A (es) Derivados de aminodihidrotiazina como inhibidores de bace para el tratamiento de la enfermedad de alzheimer
EA201000642A1 (ru) 2'-фтор-2'-дезокситетрагидроуридины в качестве ингибиторов цитидиндеаминазы
EA201200669A1 (ru) ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα
ATE517869T1 (de) Herstellung substituierter morphinan-6-one und salzen und zwischenprodukten davon
EA200901529A1 (ru) Производные арилоазол-2-илцианоэтиламина, способ их получения и способ их применения
CR11659A (es) Inhibidores de hsp90
EA200701588A1 (ru) Способы получения замещённых фенилпиразолмочевин
EA200900090A1 (ru) Бензиламины, способ их получения и их применение в качестве противовоспалительных средств
CU20100115A7 (es) Intermedios útiles para la preparación de derivados de carboxamida como antagonistas del receptor muscarínico
DK2190426T3 (da) Griseofulvin-analoger til behandling af cancer ved hæmning af centrosomal clusterdannelse
MX2008012424A (es) Proceso convergente para la sintesis de derivados de taxanos.
CR11452A (es) 5-((3,3,3-trifluoro-2-hidroxi-1-arilpropil)amino)-1h-quinolin-2-onas, un proceso para su produccion y su uso como agentes antiflamatorios
EA200601895A1 (ru) 3-(4-гетероарилциклогексиламино)циклопентанкарбоксамиды в качестве модуляторов хемокиновых рецепторов
NO20074047L (no) Ny fremgangsmate for fremstilling av substituerte indoler
CR9670A (es) Diazepinoquinolinas, sintesis de las mismas, e intermediarios para obtenerlas
CR9885A (es) Metodos para preparar derivados de acido glutamico
UY29036A1 (es) Derivados de oxopiperidina, su preparacion y su aplicacion en terapeutica
BR0208812A (pt) Derivados fenil heterociclil éter como inibidores de recaptação de serotonina
BRPI0518613A2 (pt) compostos, composiÇço farmacÊutica, mÉtodo de preparar uma composiÇço, e, uso de um composto
ES2333026T3 (es) Derivados de ciclohexil-1,4-diamina sustituidos.
EA200970355A1 (ru) Новый кристалл (s)-(+)-2-(2-хлорфенил)-2-гидроксиэтилкарбамата
TW200635905A (en) Processes for producing 4-aminoquinazolines
TNSN07462A1 (en) Ampa receptor potentiators